As Founder and Chief Executive Officer of TwelveStone Health Partners, Shane Reeves has built a best-in-class specialty infusion center organization that covers 6 states and 30 sites. With patient experience data including more than 3,000 5-star ratings, TwelveStone has become a model of care delivery focus on those with chronic long-term conditions.
The move toward infusion centers as the preferred site of care is not a short-term response. It aligns with broader industry trends, including specialty drug pipelines that continue to favor infused biologics and a sustained rise in infusion demand.
As specialty therapies expand and chronic conditions rise, infusion services must be viewed as both clinically intensive and deeply human.
Veradigm examines key clinical trends, comorbidity profiles, and treatment trends across adolescence, reproductive years, and peri-/post-menopause. Download it today!
A delayed diagnosis can cause a progression in severity (from mild to moderate to severe), increased suffering for the entire family, as well as enhance the risk of long-term neurological damage and the time it takes for them to heal.
By focusing on integrating care teams, expanding community programs, and addressing SDoH through policy reform, we can create a healthcare system that serves all patients — especially those most in need.
Losing these retail medication outlets creates more than just pharmacy deserts. In many low-income and underserved areas, drugstores also serve as grocery stores and hubs for essential services, and hence their closures mean communities lose crucial access points for a variety of goods and services.
Despite misconceptions about its use, artificial intelligence (AI), through modalities such as machine learning models, is poised to enable companies to expedite the drug design process.
Small practices play a critical role in healthcare delivery, but they cannot continue to absorb ever-increasing administrative demands without consequences.
Healthcare has traditionally been built around the convenience of the provider and not the patient. Worse, it tends to treat all patients the same regardless of the condition they are trying to manage. If we want to improve medication compliance, we have to make access, support, and most importantly financial assistance a priority.